(Q42422791)

30 October 2017

0 references

Hepatotoxicity of antituberculosis drugs (English)

1 reference

30 October 2017

1 reference

L P Ormerod

1

1 reference

30 October 2017

C Skinner

series ordinal

2

1 reference

30 October 2017

J Wales

series ordinal

3

1 reference

30 October 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

30 October 2017

1 reference

30 October 2017

51

1 reference

30 October 2017

2

1 reference

30 October 2017

111-113

1 reference

Anti-tuberculous therapy and acute liver failure.

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Hepatotoxicity caused by the combined action of isoniazid and rifampicin

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Adverse effects of antituberculosis drugs

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Ocular toxicity from ethambutol

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Fatal hepatotoxicity of anti-tubercular chemotherapy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Hepatitis cases in isoniazid treated groups and in a control group

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473008

Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8711637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8711637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of Rifampicin and Isoniazid on Liver Function

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8711637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.51.2.111

1 reference

30 October 2017

1 reference

30 October 2017

1 reference